Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Heliox improves hemodynamics in mechanically ventilated patients with chronic obstructive pulmonary disease with systolic pressure variations.

OBJECTIVE: To test the hypothesis that, compared with air-oxygen, heliox would improve cardiac performance in mechanically ventilated patients with severe chronic obstructive pulmonary disease and systolic pressure variations >15 mm Hg and to determine clinical variables associated with favorable hemodynamic responses to heliox.

DESIGN: A prospective interventional study.

SETTING: Medical and respiratory intensive care units at a university-affiliated tertiary medical center.

PATIENTS: Twenty-five consecutive mechanically ventilated patients with severe chronic obstructive pulmonary disease and acute respiratory failure who had systolic pressure variations >15 mm Hg.

INTERVENTIONS: Respiratory and hemodynamic measurements were taken at the following time with the same ventilator setting: a) baseline; b) after 30 mins with heliox; and c) 30 mins after return to air-oxygen.

MEASUREMENTS AND MAIN RESULTS: Heliox ventilation decreased intrinsic positive end-expiratory pressure (air-oxygen vs. heliox [mean +/- sd] 13 +/- 4 cm H2O vs. 5 +/- 2 cm H2O, p < .05), trapped lung volume (air-oxygen vs. heliox 362 +/- 67 mL vs. 174 +/- 86 mL, p < .05), and respiratory changes in systolic pressure variations (DeltaPP) (air-oxygen vs. heliox 29 +/- 5% vs. 13 +/- 7%, p < .05). In the ten patients with pulmonary arterial catheters, heliox decreased mean pulmonary arterial pressure, right atrial pressure, and pulmonary arterial occlusion pressure and increased cardiac index. Preheliox DeltaPP correlated with the magnitude of reduction in intrinsic positive end-expiratory pressure during heliox ventilation. Age, preheliox Paco2, and ratio of forced expiratory volume at first second to forced vital capacity correlated inversely, whereas preheliox DeltaPP correlated positively with increases in cardiac index.

CONCLUSIONS: Heliox may be a useful adjunct therapy in patients with severe chronic obstructive pulmonary disease during acute respiratory failure who have persistent intrinsic positive end-expiratory pressure-induced hemodynamic changes despite ventilator management.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app